We reported previously on the distribution of vitamin K in the rat (Thijssen & DrittijReijnders, 1994) . A tissue-selective distribution of phylloquinone (K,) was observed, with high levels in liver and heart tissue, and low levels in, for instance, brain. Surprisingly, all tissues examined contained the K-vitamin menaquinone-4 (MK-4). MK-4 differs from K, in that the phytyl side-chain of the latter is replaced by an all-trans poly (n 4) isoprenoid chain. Exocrine organs like pancreas and salivary gland, particularly, were found to contain high levels, but brain, kidney and cartilagenous tissue also contained MK-4 levels which exceeded K, stores. Furthermore, the study showed dietary K, to be a source of tissue MK-4. The vitamin K distribution in rat tissues only partly coincides with the presence of known aspects of vitamin K metabolism. For example, enzymes of the vitamin K cycle, vitamin-K-dependent carboxylase and vitamin K epoxide reductase, have not been detected in heart and brain tissue (Friedman & Smith, 1977; Thijssen & Baars, 1991) . The typical distribution pattern may suggest an, as yet, unknown physiological function of vitamin K. So far it is known that K-vitamin forms function as essential cofactors in the posttranslational carboxylase reaction converting glutamate residues of distinct substrate proteins into y-carboxyglutamates (Gla; Vermeer, 1990) . Gla-containing proteins are known to originate from liver (the coagulation proteins 11, VII, IX, X, and the anticoagulation factors protein C and protein S), from bone (bone Gla protein (BGP), matrix Gla protein (MGP), and protein S), and from endothelium (protein S) (Fair et al. 1986) . It is probable that renal tissue also forms Gla proteins which are secreted in urine (Gallop et al. 1980 ).
Here we report on the vitamin-K status in postmortem human tissue samples. The observational findings show vitamin K distributions comparable to those observed in the rat, strengthening the suggestion of a, hitherto unrecognized, additional function@) of this vitamin.
MATERIALS AND METHODS
Human tissue samples were from autopsies. The samples were obtained through the Department of Pathology of the University Hospital. The samples were from autopsies performed within 6 h of death. Autopsy samples were stored at -70" until analysed. Table  1 summarizes the histories of the autopsy samples. Tissues were homogenized in phosphate-buffered saline, one part in three volumes, using an Ultra Turrax blender at 20000 rev./min. A 0.5 ml portion of each homogenate was made up to 1 ml with water. The mixture was thoroughly mixed with 2 ml ethanol containing 400 pg 2',3'-dihydrophylloquinone (a gift from Hoffmann-La Roche, Basel, Switzerland) as internal standard. The final mixture was extracted with 3.5 ml n-hexane. The hexane phase was evaporated to dryness under a gentle stream of 0,-free N, at 30' . The residue was taken up in 2 ml nhexane and absorbed onto a silica gel column (500mg silica gel 60, 40-63,u, Merck, Darmstadt, Germany). The column was washed with 5 ml ethylacetate in n-hexane (2 ml/l) whereafter the vitamin-K-containing fraction was eluted with 3 ml ethylacetate in nhexane (20 ml/l). The recovered fraction was evaporated to dryness and the residue taken up in 0.025 ml propan-2-01. The K-vitamins were assayed by fluorescence detection (excitation, 244 nm; emission, 420 nm) following HPLC separation and post-column reduction as described previously (Thijssen & Drittij-Reijnders, 1994) . The recovery and precision of the assay were estimated from spiked homogenates of vitamin K-deficient rat liver. The percentage recoveries for MK-4 and K, were 85 (SD 21) and 103 (SD lo), 88 (SD 5) and 90 (SD 16), 97 (SD 10) and 106 (SD 3) for wet weight liver tissue contents of 0.6, 2, and 4 ng/g respectively (n 4). For MK-6-9 the percentage recoveries were 88 (SD 13), 83 (SD 6), 83 (SD 9), and 81 (SD 10) for 2 ng/g tissue contents, 85 (SD 5), 81 (SD 5), 80 (SD ll), and 86 (SD 4) for 4 ng/g tissue contents (n 4). K, and MK-4 were purchased from Sigma Chemicals (St Louis, MO, USA). MK-6-9 and 2',3'-dihydrophylloquinone were a gift from Hoffman La Roche (Basel, Switzerland). To analyse the contents of MK-10 and -1 1 the following approach was employed: (1) the retention times of MK-10 and MK-11 were predicted from the linear relationship between n, the number of isoprenoids in the side chain, and the logarithm of the capacity factor k (= (ta-to)/to, where to and t, are the retention times of the void volume and the component respectively). The relationship was estimated for MK-4, and MK-6-9; I 0999, P < 0.0001 ; (2) the fluorimetric responses per mole of the K vitamins, i.e. K,, MK-4, MK-6 9 , following the post-column reduction were found to be equal. The same was assumed to hold for MK-10 and MK-11.
RESULTS
Typical examples of chromatograms are given in Fig. 1 . In the absence of postcolumn reducing conditions the detector signal at the positions of the vitamin-K peaks returned to baseline level except for MK-6 where some of the liver samples showed an endogenous peak.
The observed tissue K, and MK-4 levels are summarized in Fig. 2 . K, was recovered in all tissue samples examined; MK-4 was also present in most of the samples. As can be seen, the levels of the vitamins varied per tissue: heart, liver, and pancreas had relatively high K, levels (medians: 9-3 (4*2), 106 (4.8), 28.4 (12-8) pmol(ng)/g tissue), lung kidney and brain were low in K, (medians: 1.5 (0.7), 0.9 (0.4), 1-5 (0.7) pmol(ng)/g). Relatively high MK-4 levels were found in pancreas, kidney and brain (medians: 21.6 (96), 6 3 ( 2 8 ) , 6.3 (2.8) pmol(ng)/g). MK-4 levels in liver were lower, except for one sample where MK-4 amounted to 21.0 pmol/g wet weight tissue. Heart-tissue samples were low in MK-4, and only one of the three lung samples contained detectable MK-4. Except for liver (r 0,972, P < 0.01, n 6), there were no significant correlations between tissue K, and MK-4 contents. However, if the liver sample with the high K, and MK-4 contents (50.8 and 21.0 pmol/g respectively) was excluded, the correlation for liver tissue was not significant either. The results show that brain contained more MK-4 than K,, MK-4: K, ratios were 2-4, 3.4 and 13.3. For kidney, three out of five samples contained higher MK-4 levels, ratios =z 10. Pancreas appeared to contain about equal amounts of the two forms of vitamin. For the other tissues there was less MK-4 than K,. The ratios are given in differences between the liver samples were apparent, some samples (livers 2 and 6) contained high amounts (more than 50% of the total K vitamin store) of MK-10 and MK-11, while others were intermediate or low in these species. The total vitamin-K store was found to range between 40 and 125 pmol/g wet weight tissue, with K, comprising 4-45 YO of it. Traces of MK-7-9 (< 2 ng/g) were also observed in some of the heart and pancreas samples but not in any of the other tissues.
DISCUSSION
This observational study on vitamin K contents in human tissues demonstrates tissueselective distributions of K, and MK-4 which, generally, are comparable to the distribution patterns observed previously in the rat, i.e. relatively high K, levels in heart and liver, low levels in other tissues. MK-4 levels were found to be 'high' in brain, kidney and pancreas. Human pancreas appears to be rich in K, also. Dietary K, is transported through the body via chylomicrons and their remnants (Saupe et al. 1993) . Little is known about the uptake by tissues. If the tissue K, distribution was a partitioning process merely based on lipophilicity, high levels in brain but not in heart or pancreas would be expected. Thus, the K, accumulations in, for example, heart and pancreas suggest some specific tissue-related phenomena. Alternatively, the observed tissue vitamin-K contents might be the result of the continuous accumulation of small amounts during the lifetime. Compared with young rats, elevated K, and MK-4 levels in old (> 24 months) rats have been observed (M. J. Drittij-Reijnders, unpublished results) . For the small number of samples in the present study no relationship was apparent with the age of the donors. One can only speculate about the source of MK-4 in human tissues. MK-4 is only a minor form of bacterial menaquinones (Kindberg et al. 1987; Conly & Stein, 1992) , and is not abundantly present in normal food products, e.g. cows' milk (Shirahata et al. 1991 ) and meat (Hirauchi et al. 1989) . We showed previously that K, can be a source of MK-4 in rats (Thijssen & Drittij-Reijnders, 1994) , either through the intervention of intestinal bacteria that may remove the phytyl side chain to release menadione (Billeter et al. 1964) or by tissue specific conversion of K, to MK-4. The latter would indicate an essential cellular function for MK-4 which cannot, or can only poorly, be replaced by K,. Alternatively, the human body is exposed to menadione which in some tissues is converted to MK-4. This also suggests a cellular need for MK-4. It is not known if human dietary products contain free menadione. More likely, menadione will be a product of the intestinal flora, formed from dietary K, (Billeter et al. 1964) or by synthesis.
The estimated K, levels in the liver are comparable with data reported previously (Shearer et al. 1988; Usui et al. 1989; Thijssen & Drittij-Reijnders, 1993) . The presence of bacterially-derived menaquinones in liver, particularly MK-10 and MK-1 1, has been reported by others (Shearer et al. 1988; Usui et al. 1989) . The higher menaquinones may even comprise the major part of the liver store. It is not clear whether they contribute to the biochemical function of vitamin K-dependent y-glutamyl carboxylation. The fact that these higher menaquinones are mainly compartmentalized in the mitochondrial fraction (Usui et al. 1989 ) may point to the contrary. In rat liver, also, the higher menaquinones were found to be mainly present in the mitochondrial fraction (Thijssen & DrittijReijnders, 1994) . The liver seems to be the main organ containing the higher menaquinones; none, or only traces, of these K-vitamins were recovered in other tissues. This is also the case in the rat (Thijssen & Drittij-Reijnders, 1994) . Hodges et al. (1993) reported the presence of MK-6-8 in human bone in amounts equal to or lower than the amount of K,.
In summary, the present study shows that some tissues accumulate K, and/or MK-4. In all probability MK-4 is synthesized in the tissues. Whether all these tissues produce specific, as yet unknown, Gla-containing proteins or whether there is a common Gla protein, e.g. matrix Gla protein (Fraser & Price, 1988) or the recently discovered vitamin-K-dependent cell-growth regulating protein (Manfioletti et al. 1993 ), remains to be investigated. As, for example, heart and brain are devoid of, or have low levels of vitamin-K-dependent carboxylase and vitamin-K (epoxide) reductase activity, the data suggest that additional physiological functions for vitamin K are still to be found.
